🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Oliver Gautschi

ORCID: 0009-0000-3137-3254
MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 5%percentile
0.452Author DataRank

Indexed papers

4in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 4 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

35P Final data from phase I/II LIBRETTO-001 trial of selpercatinib in RET fusion-positive non-small cell lung cancer

ESMO Open(2024)10.1016/j.esmoop.2024.102614
Top 42%
0.452DataRank
Top 42%8 citations

Alexander Drilon, Benjamin Solomon, Pascale Tomasini, Herbert H. Loong, Filippo de Braud +7 more

Papers

Driven by 8 papers — median percentile 29. Top paper: “Intracranial Efficacy of Selpercatinib in RET Fusion-Positive Non–Small Cell Lung Cancers on the LIBRETTO-001 Trial”.

Intracranial Efficacy of Selpercatinib in RET Fusion-Positive Non–Small Cell Lung Cancers on the LIBRETTO-001 Trial

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-0800
N/A
3.5DataRank · unranked
140 citations

Justin F. Gainor, Geoffrey R. Oxnard, Daniel Shao-Weng Tan, Dwight H. Owen, Byoung Chul Cho +16 more

Crizotinib in the Treatment of Non–Small-Cell Lung Cancer

Clinical Lung Cancer(2013)10.1016/j.cllc.2013.04.006
N/A
0.578DataRank · unranked
46 citations

Oliver Gautschi, Sacha I. Rothschild

35P Final data from phase I/II LIBRETTO-001 trial of selpercatinib in RET fusion-positive non-small cell lung cancer

ESMO Open(2024)10.1016/j.esmoop.2024.102614
Top 42%
0.452DataRank
Top 42%8 citations

Alexander Drilon, Benjamin Solomon, Pascale Tomasini, Herbert H. Loong, Filippo de Braud +7 more

Data from Intracranial Efficacy of Selpercatinib in RET Fusion-Positive Non–Small Cell Lung Cancers on the LIBRETTO-001 Trial

(2023)10.1158/1078-0432.c.6530655.v1
N/A
0DataRank · unranked
0 citations

Justin F. Gainor, Geoffrey R. Oxnard, Daniel S.W. Tan, Dwight H. Owen, Byoung Chul Cho +16 more

Supplementary Table S2 from Intracranial Efficacy of Selpercatinib in RET Fusion-Positive Non–Small Cell Lung Cancers on the LIBRETTO-001 Trial

(2023)10.1158/1078-0432.22481301
Top 100%
0DataRank
Top 100%0 citations

Justin F. Gainor, Geoffrey R. Oxnard, Daniel S.W. Tan, Dwight H. Owen, Byoung Chul Cho +16 more

Effectiveness of a Nurse-Led Patient Education for Oncology Patients to Promote Self-Management in Pain Therapy – An Exploratory Before-After Study

Pain Management Nursing(2026)10.1016/j.pmn.2025.09.006
N/A
0DataRank · unranked
0 citations

Caroline Müller, Luzia Vetter, Oliver Gautschi, Lucas M. Bachmann, Stefan Aebi +2 more

Clinical activity of MAPK targeted therapies in patients with non-V600 BRAF mutant tumors

medRxiv(2022)10.1101/2022.02.17.22271120
N/A
0DataRank · unranked
1 citations

Yifan Wang, Rouhi Fazelzad, Benny Johnson, Caroline A. Nebhan, Ibiayi Dagogo‐Jack +24 more

Somatic rearrangements causing oncogenic ectodomain deletions of FGFR1 in squamous cell lung cancer

Journal of Clinical Investigation(2023)10.1172/jci170217
N/A
0DataRank · unranked
12 citations

Lucia Nogová, Martijn H.A. van Attekum, Lukas Maas, Johannes Brägelmann, Christoph Bartenhagen +29 more